The microbiome role in cardiovascular diseases: A systematic review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/10216/150359 |
Resumo: | Background: Cardiovascular Diseases (CVD) are a set of heterogeneous diseases affecting the heart and blood vessels whose underlying cause of the development is most often atherosclerosis. The basic mechanisms of atherosclerosis involve a complex interaction of vasculature, the immune system, and lipid metabolism. The gut microbiome plays a role in these mechanisms, with most of the contributions related to microbial metabolites. Therefore, it is crucial to clarify the link between the gut microbiome and cardiovascular diseases in humans to find new possible therapeutic pathways for the foreseeable future. Objectives: The purpose of this study is to systematize and evaluate the relationship between the gut microbiome and CVD, in human-based studies. Methods: The literary research was carried out at MEDLINE and Web of Science. Based on PRISMA Guidelines, were included human-based observational and experimental studies assessing gut microbiome and CVD, namely Atrial Fibrillation (AF), Heart Failure (HF) and stroke. Results: Overall, when compared with controls, higher TMAO levels were associated with CV diseases' patients. Relatively to the gut microbiota, the predominant phyla were Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria. In AF, patients' samples were enriched with the genera Bacteroides, Parabacteroides, Enterococcus, Dorea, Ruminococcus, and Streptococcus. In HF patients, there was an increase in the genera Streptococcus and Veillonella. Studies with stroke patients reported the family Enterobacteriaceae and its genus Enterobacter enrichment. Conclusions: Despite the lack of quantitative data regarding metabolites and microbiota, this study supports a relationship between the pathophysiology of CVD and the gut microbiome. However, this work also demonstrates that there is a vast set of very heterogeneous studies, without sample power, that affect the construction of a strong evidence between the gut microbiome and CVD. |
id |
RCAP_5f11eb82cea6ce3361af09833a170804 |
---|---|
oai_identifier_str |
oai:repositorio-aberto.up.pt:10216/150359 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The microbiome role in cardiovascular diseases: A systematic reviewCiências da saúdeHealth sciencesBackground: Cardiovascular Diseases (CVD) are a set of heterogeneous diseases affecting the heart and blood vessels whose underlying cause of the development is most often atherosclerosis. The basic mechanisms of atherosclerosis involve a complex interaction of vasculature, the immune system, and lipid metabolism. The gut microbiome plays a role in these mechanisms, with most of the contributions related to microbial metabolites. Therefore, it is crucial to clarify the link between the gut microbiome and cardiovascular diseases in humans to find new possible therapeutic pathways for the foreseeable future. Objectives: The purpose of this study is to systematize and evaluate the relationship between the gut microbiome and CVD, in human-based studies. Methods: The literary research was carried out at MEDLINE and Web of Science. Based on PRISMA Guidelines, were included human-based observational and experimental studies assessing gut microbiome and CVD, namely Atrial Fibrillation (AF), Heart Failure (HF) and stroke. Results: Overall, when compared with controls, higher TMAO levels were associated with CV diseases' patients. Relatively to the gut microbiota, the predominant phyla were Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria. In AF, patients' samples were enriched with the genera Bacteroides, Parabacteroides, Enterococcus, Dorea, Ruminococcus, and Streptococcus. In HF patients, there was an increase in the genera Streptococcus and Veillonella. Studies with stroke patients reported the family Enterobacteriaceae and its genus Enterobacter enrichment. Conclusions: Despite the lack of quantitative data regarding metabolites and microbiota, this study supports a relationship between the pathophysiology of CVD and the gut microbiome. However, this work also demonstrates that there is a vast set of very heterogeneous studies, without sample power, that affect the construction of a strong evidence between the gut microbiome and CVD.2023-06-062023-06-06T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/10216/150359TID:203523342engSara Miguel Cardeal Douradoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-16T01:23:01Zoai:repositorio-aberto.up.pt:10216/150359Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:44:32.950455Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The microbiome role in cardiovascular diseases: A systematic review |
title |
The microbiome role in cardiovascular diseases: A systematic review |
spellingShingle |
The microbiome role in cardiovascular diseases: A systematic review Sara Miguel Cardeal Dourado Ciências da saúde Health sciences |
title_short |
The microbiome role in cardiovascular diseases: A systematic review |
title_full |
The microbiome role in cardiovascular diseases: A systematic review |
title_fullStr |
The microbiome role in cardiovascular diseases: A systematic review |
title_full_unstemmed |
The microbiome role in cardiovascular diseases: A systematic review |
title_sort |
The microbiome role in cardiovascular diseases: A systematic review |
author |
Sara Miguel Cardeal Dourado |
author_facet |
Sara Miguel Cardeal Dourado |
author_role |
author |
dc.contributor.author.fl_str_mv |
Sara Miguel Cardeal Dourado |
dc.subject.por.fl_str_mv |
Ciências da saúde Health sciences |
topic |
Ciências da saúde Health sciences |
description |
Background: Cardiovascular Diseases (CVD) are a set of heterogeneous diseases affecting the heart and blood vessels whose underlying cause of the development is most often atherosclerosis. The basic mechanisms of atherosclerosis involve a complex interaction of vasculature, the immune system, and lipid metabolism. The gut microbiome plays a role in these mechanisms, with most of the contributions related to microbial metabolites. Therefore, it is crucial to clarify the link between the gut microbiome and cardiovascular diseases in humans to find new possible therapeutic pathways for the foreseeable future. Objectives: The purpose of this study is to systematize and evaluate the relationship between the gut microbiome and CVD, in human-based studies. Methods: The literary research was carried out at MEDLINE and Web of Science. Based on PRISMA Guidelines, were included human-based observational and experimental studies assessing gut microbiome and CVD, namely Atrial Fibrillation (AF), Heart Failure (HF) and stroke. Results: Overall, when compared with controls, higher TMAO levels were associated with CV diseases' patients. Relatively to the gut microbiota, the predominant phyla were Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria. In AF, patients' samples were enriched with the genera Bacteroides, Parabacteroides, Enterococcus, Dorea, Ruminococcus, and Streptococcus. In HF patients, there was an increase in the genera Streptococcus and Veillonella. Studies with stroke patients reported the family Enterobacteriaceae and its genus Enterobacter enrichment. Conclusions: Despite the lack of quantitative data regarding metabolites and microbiota, this study supports a relationship between the pathophysiology of CVD and the gut microbiome. However, this work also demonstrates that there is a vast set of very heterogeneous studies, without sample power, that affect the construction of a strong evidence between the gut microbiome and CVD. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-06-06 2023-06-06T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/10216/150359 TID:203523342 |
url |
https://hdl.handle.net/10216/150359 |
identifier_str_mv |
TID:203523342 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799135761595891712 |